Hill-Rom Holdings Inc (NYSE:HRC) issued its quarterly earnings results on Friday. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01, Bloomberg Earnings reports. The business had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a net margin of 5.80% and a return on equity of 19.77%. The business’s revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.81 earnings per share. Hill-Rom Holdings updated its Q4 guidance to $1.26-1.30 EPS.

Hill-Rom Holdings (NYSE HRC) traded down 6.22% during mid-day trading on Friday, reaching $74.74. 2,063,064 shares of the company’s stock traded hands. Hill-Rom Holdings has a 12 month low of $50.50 and a 12 month high of $84.65. The firm’s 50-day moving average price is $80.79 and its 200 day moving average price is $71.74. The stock has a market capitalization of $5.06 billion, a PE ratio of 43.55 and a beta of 1.23.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be paid a $0.18 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.96%. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 41.62%.

In other news, SVP Andreas G. Frank sold 10,660 shares of the stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the completion of the sale, the senior vice president now directly owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Paul Sherwood Johnson sold 2,078 shares of the stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $72.30, for a total value of $150,239.40. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Hill-Rom Holdings by 17.5% in the first quarter. Vanguard Group Inc. now owns 5,737,481 shares of the medical technology company’s stock valued at $405,066,000 after buying an additional 853,385 shares in the last quarter. BlackRock Inc. raised its position in shares of Hill-Rom Holdings by 13,535.4% in the first quarter. BlackRock Inc. now owns 5,067,064 shares of the medical technology company’s stock worth $357,736,000 after buying an additional 5,029,903 shares during the last quarter. State Street Corp raised its position in shares of Hill-Rom Holdings by 3.4% in the first quarter. State Street Corp now owns 1,637,462 shares of the medical technology company’s stock worth $115,603,000 after buying an additional 53,082 shares during the last quarter. Neuberger Berman Group LLC raised its position in shares of Hill-Rom Holdings by 15.6% in the first quarter. Neuberger Berman Group LLC now owns 1,480,242 shares of the medical technology company’s stock worth $104,505,000 after buying an additional 199,901 shares during the last quarter. Finally, Bank of Montreal Can raised its position in shares of Hill-Rom Holdings by 2.1% in the second quarter. Bank of Montreal Can now owns 1,007,525 shares of the medical technology company’s stock worth $80,206,000 after buying an additional 20,495 shares during the last quarter. 83.81% of the stock is owned by institutional investors.

A number of brokerages recently issued reports on HRC. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $80.00 price target for the company in a research note on Monday, April 3rd. Cantor Fitzgerald set a $86.00 price target on shares of Hill-Rom Holdings and gave the stock a “hold” rating in a research note on Friday. BidaskClub lowered shares of Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Morgan Stanley lifted their price target on shares of Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Friday, June 30th. Finally, Barclays PLC lifted their price target on shares of Hill-Rom Holdings from $70.00 to $75.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 19th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $88.17.

WARNING: “Hill-Rom Holdings Inc (HRC) Posts Earnings Results, Beats Expectations By $0.01 EPS” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.watchlistnews.com/hill-rom-holdings-inc-hrc-posts-earnings-results-beats-expectations-by-0-01-eps/1462947.html.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Earnings History for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.